Condition: Brain Metastases · Brain Metastases, Adult · Brain Cancer · Sponsor: Baptist Health South Florida
This is a pilot imaging study in participants treated with stereotactic radiosurgery (SRS) to treat brain metastasis. The purpose of this study is to see whether 18F-Fluciclovine positron emission tomography (PET) can be used as a biomarker to measure response or progression of brain metastasis after SRS.
This description comes directly from the study's public registry record.
Rupesh Kotecha, M.D. · (786) 596-2000 · RupeshK@baptisthealth.net
Kristy Reyes · (786) 596-2000 · Kristina.Reyes@baptisthealth.net
Always discuss trial participation with your own doctor first.
| Miami Cancer Institute | Miami, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06048094